254 related articles for article (PubMed ID: 32628595)
1. Anticancer Active Heterocyclic Chalcones: Recent Developments.
Dandawate P; Ahmed K; Padhye S; Ahmad A; Biersack B
Anticancer Agents Med Chem; 2021; 21(5):558-566. PubMed ID: 32628595
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Selective Cytotoxic Activities on Rhabdomyosarcoma and Noncancerous Cells of Some Heterocyclic Chalcones.
Do TH; Nguyen DM; Truong VD; Do TH; Le MT; Pham TQ; Thai KM; Tran TD
Molecules; 2016 Mar; 21(3):329. PubMed ID: 27005608
[TBL] [Abstract][Full Text] [Related]
3. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
4. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
5. Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents.
Atukuri D; S V; R S; L V; R P; M M R
Bioorg Chem; 2020 Dec; 105():104419. PubMed ID: 33142228
[TBL] [Abstract][Full Text] [Related]
6. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Cytotoxic Activities of Difluoro-Dimethoxy Chalcones.
Yamali C; Gul HI; Ozgun DO; Sakagam H; Umemura N; Kazaz C; Gul M
Anticancer Agents Med Chem; 2017; 17(10):1426-1433. PubMed ID: 28356013
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.
Dyrager C; Wickström M; Fridén-Saxin M; Friberg A; Dahlén K; Wallén EA; Gullbo J; Grøtli M; Luthman K
Bioorg Med Chem; 2011 Apr; 19(8):2659-65. PubMed ID: 21459004
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones.
Cagir A; Odaci B; Varol M; Akcok I; Okur O; Koparal AT
Anticancer Agents Med Chem; 2018 Feb; 17(14):1915-1923. PubMed ID: 28554313
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
12. Recent advances of cytotoxic chalconoids targeting tubulin polymerization: Synthesis and biological activity.
Mirzaei H; Emami S
Eur J Med Chem; 2016 Oct; 121():610-639. PubMed ID: 27318983
[TBL] [Abstract][Full Text] [Related]
13. Updates on Receptors Targeted by Heterocyclic Scaffolds: New Horizon in Anticancer Drug Development.
Kharb R
Anticancer Agents Med Chem; 2021; 21(11):1338-1349. PubMed ID: 32560614
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Fluorescence Properties of 4-Dialkylaminochalcones and Investigation of the Cytotoxic Mechanism of Chalcones.
Zhou B; Jiang P; Lu J; Xing C
Arch Pharm (Weinheim); 2016 Jul; 349(7):539-52. PubMed ID: 27214789
[TBL] [Abstract][Full Text] [Related]
15. A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.
Liu W; He M; Li Y; Peng Z; Wang G
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):9-38. PubMed ID: 34894980
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship studies of furan-ring fused chalcones as antiproliferative agents.
Saito Y; Kishimoto M; Yoshizawa Y; Kawaii S
Anticancer Res; 2015 Feb; 35(2):811-7. PubMed ID: 25667461
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimicrobial evaluation of some heterocyclic chalcone derivatives.
Hamada NM; Sharshira EM
Molecules; 2011 Mar; 16(3):2304-12. PubMed ID: 21389908
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and identification of α-cyano bis(indolyl)chalcones as novel anticancer agents.
Kumar D; Maruthi Kumar N; Tantak MP; Ogura M; Kusaka E; Ito T
Bioorg Med Chem Lett; 2014 Nov; 24(22):5170-4. PubMed ID: 25442306
[TBL] [Abstract][Full Text] [Related]
19. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Biological Evaluation of 1,2,3-triazole tethered Pyrazoline and Chalcone Derivatives.
Hussaini SM; Yedla P; Babu KS; Shaik TB; Chityal GK; Kamal A
Chem Biol Drug Des; 2016 Jul; 88(1):97-109. PubMed ID: 26854643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
